Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1987;9:139-143

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Overlack, A.
Right arrow Articles by Stumpe, K. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Overlack, A.
Right arrow Articles by Stumpe, K. O.

Hypertension, Vol 9, 139-143, Copyright © 1987 by American Heart Association


ARTICLES

Influence of magnesium on blood pressure and the effect of nifedipine in rats

A Overlack, JG Zenzen, C Ressel, HM Muller and KO Stumpe

The influence of long-term alterations in dietary magnesium intake on blood pressure and on the antihypertensive effect of the calcium antagonist nifedipine was investigated in normotensive Wistar-Kyoto (WKY) and in spontaneously hypertensive rats (SHR). The rats were fed a diet either high (1%), normal (0.1%), or low (0.01%) in magnesium for 12 weeks (WKY) and 20 weeks (SHR), respectively. Nifedipine was added to the diet for 4 weeks in concentrations of 300 and 1000 ppm. Each dose was given for 2 weeks. Plasma and intraerythrocytic concentrations of sodium, potassium, and magnesium were measured before and at the end of nifedipine treatment. Blood was obtained by cardiac puncture. In the WKY and SHR, blood pressure was not influenced by magnesium intake. The blood pressure-lowering effect of nifedipine was most pronounced on normal dietary magnesium and was significantly suppressed in the magnesium-deficient rats. Plasma and intracellular total magnesium concentrations were consistently increased during high and reduced during low dietary intake of the ion. Intracellular sodium concentration increased during magnesium deficiency and was normalized by nifedipine. The marked and long-term alterations in plasma and intracellular concentrations of magnesium did not influence arterial blood pressure levels in either the normotensive WKY or the SHR. Therefore, dietary magnesium intake does not appear to play an important role in long-term regulation of blood pressure in rats. However, magnesium depletion attenuates the blood pressure-lowering effect of nifedipine.


This article has been cited by other articles:


Home page
StrokeHome page
H. Iso, M. J. Stampfer, J. E. Manson, K. Rexrode, C. H. Hennekens, G. A. Colditz, F. E. Speizer, and W. C. Willett
Prospective Study of Calcium, Potassium, and Magnesium Intake and Risk of Stroke in Women
Stroke, September 1, 1999; 30(9): 1772 - 1779.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
D. M. Cummings, P. Amadio Jr, L. Nelson, and J. M. Fitzgerald
The Role of Calcium Channel Blockers in the Treatment of Essential Hypertension
Arch Intern Med, February 1, 1991; 151(2): 250 - 259.
[Abstract] [PDF]